Data from ImmunoGenesis’ Lead Programs Presented in Six Posters at Society for Immunotherapy of Cancer (SITC) Conference

By WebmasterNovember 15, 2021November 1st, 2024No Comments

Data from ImmunoGenesis’ Lead Programs Presented in Six Posters at Society for Immunotherapy of Cancer (SITC) Conference

Previous PostRenovacor Announces Third Quarter 2021 Financial Results and Provides Corporate Update
Next PostRelmada Therapeutics Provides Corporate Update and Reports Third Quarter 2021 Financial Results